Subscribe to Newsletter

Advanced Medicine

Manufacture Advanced Medicine

Cell and Gene Champions Speak Up

| Angus Stewart

Get a sharp perspective on the cell and gene status quo in The Medicine Maker 2022 supplement on advanced medicine

Discovery & Development Drug Delivery

Lipid Nanoparticles: From Little League to the Majors

| Bowen Tian | 8 min read

What does the future hold for lipid nanoparticles?

Discovery & Development Translational Science

From Arctic Fish To New Cell Therapy Preservation Technologies

| Maryam Mahdi | 2 min read

Cryopreservation should maintain the viability of organs and cell therapies, but the process is riddled with challenges.

Manufacture Advanced Medicine

The Nucleic Acid Revolution

| Tommy Duncan | 3 min read

Could nucleic acid medicines be the solution to the complex problems associated with advanced therapy manufacture?

Business & Regulation Business Practice

Who Are the Best Companies in the Pharma Field?

| 2 min read

Voting is now open for the 2023 Company of the Year Awards – make sure you have your say!

Manufacture Advanced Medicine

Memories From the Start of the Gene Therapy Wave

| Stephanie Vine | 10 min read

The remarkable story of gene therapy drug development during the 1990s and early 2000s.

Manufacture Advanced Medicine

The Pros and Cons of Lentiviral and Adeno-Associated Viral Vectors

| Suparna Sanyal | 5 min read

Demand for gene therapies is rising, so all the more reason to better understand the properties of their delivery devices

Business & Regulation Standards & Regulation

Unproven Stem Cell Ruling Creates Uncertainty

| Stephanie Vine | 2 min read

ISCT speaks out after US court rules that stem cell therapy does not fall under FDA jurisdiction.

Business & Regulation Profession

Change Is the Only Constant

| Angus Stewart | 9 min read

Diversity, support networks, and unexpected journeys: what nine years of C&G biz wisdom can teach us

Manufacture Advanced Medicine

The Patient Experience Trumps All

| Cedric Picaud | 3 min read

How can companies realistically incorporate patient-centric practices into cell and gene product development?

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register